BNTX

BioNTech SE Healthcare - Biotechnology Investor Relations →

YES
7.3% BELOW
↓ Approaching Was -1.3% last week
-15% -10% -5% 0% 5% 10% 15%+
Buy Threshold $114.98
14-Week RSI 52

BioNTech SE (BNTX) closed at $106.62 as of 2026-02-02, trading 7.3% below its 200-week moving average of $114.98. This places BNTX in the deep value zone. The stock is currently moving closer to the line, down from -1.3% last week. The 14-week RSI sits at 52, indicating neutral momentum.

Over the past 282 weeks of data, BNTX has crossed below its 200-week moving average 3 times. On average, these episodes lasted 54 weeks. The average one-year return after crossing below was -14.3%, suggesting these dips have not historically been reliable buying opportunities for this stock.

With a market cap of $26.8 billion, BNTX is a large-cap stock. Free cash flow yield is currently negative, meaning the company is burning cash. Return on equity stands at -3.0%. The stock trades at 1.2x book value.

Over the past 5.5 years, a hypothetical investment of $100 in BNTX would have grown to $147, compared to $223 for the S&P 500. BNTX has returned 7.2% annualized vs 15.7% for the index, underperforming the broader market over this period.

Free cash flow has been declining at a -100% compound annual rate. A deteriorating cash flow trend warrants extra scrutiny — the stock may be cheap for a reason.

Growth of $100: BNTX vs S&P 500

Monthly data normalized to $100 at start. Vertical dashed lines mark 200-week MA touches.

What Happens After BNTX Crosses Below the Line?

Across 3 historical episodes, buying BNTX when it crossed below its 200-week moving average produced an average return of -26.7% after 12 months (median -30.0%), compared to +23.7% for the S&P 500 over the same periods. After 24 months, the average return was -24.0% vs +56.3% for the index.

Each line shows $100 invested at the moment BNTX crossed below its 200-week MA. Bold blue = stock average. Gray dashed = S&P 500 average over same periods.

Advertisement

Historical Touches

BNTX has crossed below its 200-week MA 3 times with an average 1-year return of +-14.3% after recovery.

Crossed BelowRecoveredWeeksMax Depth1-Year ReturnReturn Since Touch
Jun 2022Jun 202226.8%-10.1%-14.8%
Sep 2022Oct 202255.7%-18.5%-16.9%
Feb 2023Ongoing155+46.0%Ongoing-20.0%
Average54+-14.3%

Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.

Data as of Friday close, 2026-02-02